Check the Biogen stock price today on the NASDAQ stock exchange and access historical BIIB stock price chart. Get the latest Biogen stock information.
A high-level overview of Biogen Inc. (BIIB) stock. View (BIIB) real-time stock price, chart, news, analysis, analyst reviews and more.
stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a ...
Biogen Inc. Common Stock (BIIB) Real-Time 本页面每 30 秒钟刷新一次。 最新更新数据 Apr 29, 2025 03:55 PM ET*Today’s High/Low is only updated during regular trading hours; and does not include trades occurring in pre-market or after-hours....
(6) Historical Performance are computed by last price and historical price of the corresponding period (7) Recent Statistic and Technical Analysis are updated every 2 minutes during trading hours (8) Change% is computed in local market currency. (9) Exchange rate today: 1 USD = 7.779 HKD...
BIIB stock is losing out today, as two major hospitals have declined to use Biogen's controversial new Alzheimer's drug on their campuses.
Dividend History).Please note that the dividend history might include the company’s preferred securities as well.Price/Earnings Ratio is a widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Actual EPS (Earnings Per ...
Spreads Protection Strategies Straddles & Strangles Horizontal Spreads Butterfly Spreads Condor Strategies company News & Headlines Key Statistics SEC Filings Competitors Stock Comparison Insider Trades analysts Earnings Estimates Analyst Ratings financials Financial Summary Income Statement Balance Sheet Cash Flow...
ABarchart Premier Membershiplets you download historical price data for any publicly available symbol we carry in our database. Access Stocks, ETF’s, Mutual Funds, Futures, Commodities, Forex and Cryptos - you can download daily data back to the inception of our database, or 1-minute data...
The stock reacted sharply to the announcement of trial data details on multiple sclerosis (MS) pill BG-12, a rival of Active Biotech's laquinimod, by US Biogen Idec Inc (NASDAQ: BIIB). -Nordea axes rating on Swedish Active Biotech to "sell" Following Biogen's (BIIB) quarterly results...